• Company
• New drug 'Truqap' for HER2- breast cancer Rx available
• by Son, Hyung Min Jan 8, 2025 05:53am

• Company
• Twice yearly HIV drug 'lenacapavir' receives ODD
• by Eo, Yun-Ho Jan 7, 2025 06:05am

• Company
• AstraZeneca Korea recertified Innovative Pharma Company
• by Whang, byung-woo Jan 7, 2025 06:05am

• Company
• 1st RSV preventive inj 'Beyfortus' can be prescribed
• by Eo, Yun-Ho Jan 6, 2025 05:56am

• Company
• Balversa may be prescribed at general hospitals in Korea
• by Eo, Yun-Ho Jan 6, 2025 05:56am

• Company
• Lily's 'Jaypirca' launches in KOR
• by Whang, byung-woo Jan 3, 2025 06:28am

• Company
• Will Fabhalta settle as a PNH treatment option in Korea?
• by Eo, Yun-Ho Jan 3, 2025 06:27am

• Company
• Yuhan’s anticancer drug Leclaza secures European approval
• by Cha, Jihyun Jan 2, 2025 06:10am

• Company
• K-Bio to showcase CDMO·new drugs at the JP Morgan
• by Son, Hyung Min Jan 2, 2025 06:10am

• Company
• Yuhan Corp will distribute Canesten·Bepanthen
• by Nho, Byung Chul Dec 30, 2024 05:57am